Key statistics
On Friday, Alto Neuroscience Inc (ANRO:NYQ) closed at 17.62, -15.72% below its 52-week high of 20.91, set on Dec 19, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 19.28 |
|---|---|
| High | 19.49 |
| Low | 17.08 |
| Bid | 10.00 |
| Offer | 17.50 |
| Previous close | 19.50 |
| Average volume | 260.59k |
|---|---|
| Shares outstanding | 31.07m |
| Free float | 29.07m |
| P/E (TTM) | -- |
| Market cap | 605.79m USD |
| EPS (TTM) | -2.31 USD |
Data delayed at least 15 minutes, as of Feb 20 2026 21:00 GMT.
More ▼
Press releases
- Alto Neuroscience Announces Completion of Enrollment in Phase 2 Proof-of-Concept Study of ALTO-101 in Cognitive Impairment Associated with Schizophrenia
- Alto Neuroscience Highlights Invited Review in American Journal of Psychiatry Establishing Neuroplasticity as a Core Driver of Psychiatric Disease and Treatment
- Alto Neuroscience Strengthens Intellectual Property Portfolio with Issuance of New Method-of-Treatment Patent for ALTO-207 in Depression
- Alto Neuroscience Presents New Data at the 64th Annual Meeting of the American College of Neuropsychopharmacology
- Alto Neuroscience Announces New Employee Inducement Grants Under NYSE Rule 303A.08
More ▼
